Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
![Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says](https://video.newsserve.net/700/v/20210129/2101292219-Johnson-Johnson-COVID-19-vaccine-is-66.jpg)
Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
Johnson & Johnson’s one-shot vaccine candidate was found to be 85% effective against the most serious symptoms of COVID-19.